Mary Murphy, - Speech-Language Pathologist in Akron, OH

Mary Murphy, is a Speech-language Pathologist based in Akron, Ohio. Mary Murphy is licensed to practice in Ohio (license number COND 2016296) and her current practice location is 200 Wyant Rd, Akron, Ohio. She can be reached at her office (for appointments etc.) via phone at (440) 382-8675.

NPI number for Mary Murphy is 1821549460 and her current mailing address is 200 Wyant Rd, Akron, Ohio. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1821549460.

Contact Information

Mary Murphy,
200 Wyant Rd,
Akron, OH 44313-4228
(440) 382-8675
Not Available



Healthcare Provider's Profile

Full NameMary Murphy
GenderFemale
SpecialitySpeech-language Pathologist
Location200 Wyant Rd, Akron, Ohio
Accepts Medicare AssignmentsDoes not participate in Medicare Program. She may not accept medicare assignment.
  NPI Data:
  • NPI Number: 1821549460
  • Provider Enumeration Date: 10/19/2016
  • Last Update Date: 10/19/2016

Medical Identifiers

Medical identifiers for Mary Murphy such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1821549460NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
235Z00000XSpeech-language Pathologist COND 2016296 (Ohio)Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Mary Murphy is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Mary Murphy,
200 Wyant Rd,
Akron, OH 44313-4228

Ph: (440) 382-8675
Mary Murphy,
200 Wyant Rd,
Akron, OH 44313-4228

Ph: (440) 382-8675

News Archive

Teva Pharmaceuticals granted final approval for Ribavirin capsules

Teva Pharmaceutical Industries has announced that the U.S. Food and Drug Administration has granted final approval for the Company's ANDA for Ribavirin Capsules, 200 mg. Shipment of this product is expected to begin immediately.

FDA-approved contrast agent improves optical imaging of stem cells

A study published in the current issue of Cell Transplantation (19:1) has found that using the FDA-approved contrast agent Indocyanine Green (ICG) to label human embryonic stem cell-derived cardiomyocytes (hESC-CMs) substantially improved efforts to optically track stem cells after transplanting them into heart tissues.

Retail meat harbors disease-causing Klebsiella pneumoniae, shows new study

Chicken, turkey and pork sold in grocery stores harbors disease-causing bacteria known as Klebsiella pneumoniae, according to a new study. The research, which was published online today in the journal Clinical Infectious Diseases, shows that contaminated meat may be an important source of human exposure to Klebsiella.

Shutting down microglia

Developing brain tumors can coax assistance from nearby cells known as microglia, according to a new study from scientists at Washington University School of Medicine in St. Louis. The researchers have identified one protein made by microglia that helps accelerate tumor growth and are looking for others.

Labopharm prices underwritten public offering of 11.7M units

Labopharm Inc. today announced that it has priced an underwritten public offering of 11,764,706 newly issued units at a public offering price of US$1.70 per unit. Each unit is comprised of one of the Company's common shares and a warrant to purchase 0.5 of a common share. Each whole warrant entitles the holder to acquire one common share of the Company upon payment of US$2.30 per share, exercisable at any time during the period beginning six months after the date of issuance and ending three years following the date of issuance.

Read more News

› Verified 1 days ago


Speech-Language Pathologist in Akron, OH

Michele Y Gunther, S.P.L
Speech-Language Pathologist
Medicare: Not Enrolled in Medicare
Practice Location: 640 W Market St, Akron, OH 44303
Phone: 330-762-5425    
Jamie Blaylock,
Speech-Language Pathologist
Medicare: Not Enrolled in Medicare
Practice Location: 450 Vernon Odom Blvd, Akron, OH 44307
Phone: 330-376-0153    
Kimberly Marie Gibbons, MA, CCC-SLP
Speech-Language Pathologist
Medicare: Not Enrolled in Medicare
Practice Location: 2425 Foxboro Ave, Akron, OH 44305
Phone: 330-631-5678    
Kristin Weaver, M.A. CCC/SLP
Speech-Language Pathologist
Medicare: Not Enrolled in Medicare
Practice Location: 640 W Market St, Akron, OH 44303
Phone: 330-762-5425    
Mrs. Elizabeth Kinzig,
Speech-Language Pathologist
Medicare: Not Enrolled in Medicare
Practice Location: 200 Wyant Rd, Akron, OH 44313
Phone: 330-836-7953    
Mrs. Andrea P. Brewer, MA, CCC-SLP
Speech-Language Pathologist
Medicare: Not Enrolled in Medicare
Practice Location: 181 Polsky Building, Akron, OH 44325
Phone: 330-972-8189    Fax: 330-972-7884
Mary Mariani-walker,
Speech-Language Pathologist
Medicare: Not Enrolled in Medicare
Practice Location: 1199 Vernon Odom Blvd, Akron, OH 44307
Phone: 330-873-3396    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.